ABG

Ally Bridge Group Portfolio holdings

AUM $119M
1-Year Est. Return 78.04%
This Quarter Est. Return
1 Year Est. Return
+78.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
+$5.08M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$15M
2
+$12.1M
3
+$10.2M
4
SLNO icon
Soleno Therapeutics
SLNO
+$8.36M
5
TSHA icon
Taysha Gene Therapies
TSHA
+$6.21M

Top Sells

1
+$15.2M
2
+$7.82M
3
+$7.37M
4
ELVN icon
Enliven Therapeutics
ELVN
+$5.64M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$4.93M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLNO icon
1
Soleno Therapeutics
SLNO
$2.84B
$20.4M 12.45%
302,483
+123,664
MDGL icon
2
Madrigal Pharmaceuticals
MDGL
$13.2B
$15M 9.12%
+32,662
ATAI icon
3
Atai Beckley NV
ATAI
$1.62B
$12.1M 7.37%
+2,287,005
ASND icon
4
Ascendis Pharma
ASND
$12.5B
$10.2M 6.18%
+51,080
LENZ
5
LENZ Therapeutics
LENZ
$903M
$8.17M 4.97%
175,363
-167,959
TSHA icon
6
Taysha Gene Therapies
TSHA
$1.36B
$6.21M 3.78%
+1,898,112
AMLX icon
7
Amylyx Pharmaceuticals
AMLX
$1.58B
$5.94M 3.62%
+437,391
CMPS
8
Compass Pathways
CMPS
$517M
$5.88M 3.58%
1,026,382
-458,618
EPRX
9
Eupraxia Pharmaceuticals
EPRX
$297M
$5.4M 3.29%
+915,000
MNPR icon
10
Monopar Therapeutics
MNPR
$513M
$5.26M 3.21%
64,455
+29,918
ARQT icon
11
Arcutis Biotherapeutics
ARQT
$3.74B
$4.4M 2.68%
+233,220
MNMD icon
12
MindMed
MNMD
$1.21B
$4.26M 2.6%
361,444
-364,728
TARS icon
13
Tarsus Pharmaceuticals
TARS
$3.45B
$4.21M 2.56%
70,778
-50,404
SLDB icon
14
Solid Biosciences
SLDB
$443M
$3.39M 2.06%
549,182
-174,818
PMN icon
15
ProMIS Neurosciences
PMN
$16.1M
$2.65M 1.61%
6,233,497
+4,899,069
AVTX icon
16
Avalo Therapeutics
AVTX
$324M
$2.26M 1.38%
+178,100
TECX
17
Tectonic Therapeutic
TECX
$389M
$2.17M 1.32%
138,595
-25,088
WHWK
18
Whitehawk Therapeutics
WHWK
$117M
$1.55M 0.95%
817,939
INSM icon
19
Insmed
INSM
$43.5B
– –
-47,710
KRRO icon
20
Korro Bio
KRRO
$64.4M
– –
-154,223
LXEO icon
21
Lexeo Therapeutics
LXEO
$659M
– –
-867,302
MLTX icon
22
MoonLake Immunotherapeutics
MLTX
$1.05B
– –
0
MRUS icon
23
Merus
MRUS
$7.29B
– –
-140,208
ORIC icon
24
Oric Pharmaceuticals
ORIC
$1.12B
– –
-485,629
CNTA
25
Centessa Pharmaceuticals
CNTA
$4.33B
– –
-293,986
1
2